Abstract
Hyperthyroidism is a common endocrine disorder affecting 2% of females and 0.5% of males worldwide and antithyroid drugs constitute the first line of treatment in the majority of cases. These agents may cause severe adverse effects and among them liver failure, although rare, is a potential lethal one. This case illustrates the sudden and abrupt deterioration of hepatic function due to antithyroid drug administration. This case along with a concise literature review is presented aiming to increase the awareness of endocrinologists of possible fatal complications from the everyday use of common agents such as antithyroid drugs.
Similar content being viewed by others
References
J. Franklyn, Clin. Med. 3, 11–15 (2003)
M. Abraham-Nordling, O. Törring, M. Lantz, B. Hallengren, H. Ohrling, G. Lundell, J. Calissendorff, G. Jörneskog, G. Wallin, Eur. J. Endocrinol. 158, 823–827 (2008)
M.P. Vanderpump, W.M. Tunbridge, J.M. French, D. Appleton, D. Bates, F. Clark, J. Grimley Evans, D.M. Hasan, H. Rodgers, F. Tunbridge, E.T. Young, Clin. Endocrinol. 43, 55–68 (1995)
D.S. Cooper, Endocrinologist 9, 457–476 (1999)
J.S. Hanson, Arch. Intern. Med. 144, 994–996 (1984)
R. Malik, H. Hodgson, QJM 95, 559–569 (2002)
D.S. Cooper, N. Engl. J. Med. 352, 905–917 (2005)
D.M. Arab, D.A. Malatjalian, R.S. Rittmaster, J. Clin. Endocrinol. Metab. 80, 1083–1085 (1995)
M.G. Fisher, H.R. Naylor, A. Miller, JAMA 223, 1028–1029 (1973)
G. Luca, S. Orietta, P. Caterina, S. Giovambattista, F. Maria, Curr. Drug Saf. 4, 204–206 (2009)
M. Majeed, A. Babu, Am. J. Med. Sci. 332, 51–53 (2006)
N.E. Mikhail, South Med. J. 97, 178–182 (2004)
L.S. Ramos-Bonner, T.H. Goldberg, S. Moyer, C. Anastasopoulou, Am. J. Geriatr. Pharmacother. 5, 236–240 (2007)
C. Ayensa, R. Diaz de Otazu, J.M. Cia, Arch. Intern. Med. 146, 1455 (1986)
H. Blom, J. Stolk, H.B.,v. Schreuder, M. van der von Blomberg-Flier, Arch. Intern. Med. 145, 1513–1515 (1985)
W.W. Dinsmore, M.D. O’Hara, M.E. Callender, N. Engl. J. Med. 309, 438 (1983)
G. Ozenne, N.D. Manchon, J. Doucet, J. Hemet, J.C. Schrub, E. Bercoff, J. Clin. Gastroenterol. 11, 95–97 (1989)
M. Weiss, D. Hassin, H. Bank, Arch. Intern. Med. 140, 1184–1185 (1980)
B.Z. Garty, R. Kauli, J. Ben-Ari, E. Lubin, M. Nitzan, Z. Laron, Drug Intell. Clin. Pharm. 19, 740–742 (1985)
C.Y. Hayashida, A.J. Duarte, A.E. Sato, E.H. Yamashiro-Kanashiro, J. Endocrinol. Invest. 13, 937–941 (1990)
A.A. Mihas, P. Holley, R.S. Koff, B.I. Hirschowitz, Gastroenterology 70, 770–774 (1976)
F. Pacini, V. Sridama, S. Refetoff, J. Endocrinol. Invest. 5, 403–407 (1982)
A. Gurlek, V. Cobaukara, M. Bayraktar, J. Clin. Gastroenterol. 24, 180–183 (1997)
A.L. Hunter, R.A. Neal, Biochem. Pharmacol. 24, 2199–2205 (1975)
D.S. Seidman, E. Livni, B. Ilie, I. Blum, J. Toxicol. Clin. Toxicol. 24, 353–360 (1986)
Y.F. Liaw, M.J. Huang, K.D. Fan, K.L. Li, S.S. Wu, T.J. Chen, Ann. Intern. Med. 118, 424–428 (1993)
H. Nakamura, J.Y. Noh, K. Itoh, S. Fukata, A. Miyauchi, N. Hamada, J. Clin. Endocrinol. Metab. 92, 2157–2162 (2007)
J.K. Ruiz, G.V. Rossi, H.A. Vallejos, R.W. Brenet, I.B. Lopez, A.A. Escribano, Ann. Pharmacother. 37, 224–228 (2003)
A. Limaye, P.R. Ruffolo, Am. J. Gastroenterol. 82, 152–154 (1987)
S.A. Rivkees, NEMJ 360, 1574–1575 (2009)
D.S. Cooper, S.A. Rivkees, J. Clin. Endocrinol. Metab. 94, 1881–1882 (2009)
Propylthiouracil-related liver toxicity (Public Workshop, Washington, D.C. April 18, 2009) www.fda.gov/CDER/meeting/ptu_toxicity.htm
B. Baker, B. Shapiro, L.M. Fig, D. Woodbury, J.C. Sisson, W.H. Beierwaltes, Thyroidology 1, 17–26 (1989)
M. Enghofer, K. Badenhoop, S. Zeuzem, A. Schmidt-Matthiesen, C. Betz, A. Encke, K. Henning, J. Clin. Endocrinol. Metab. 85, 1765–1769 (2000)
M. Levy, Clin. Pediatr. 32, 25–29 (1993)
Y. Ichiki, M. Akahoshi, N. Yamashita, C. Morita, T. Maruyama, T. Horiuchi, K. Hayashida, H. Ishibashi, Y. Niho, J. Gastroenterol. 33, 747–750 (1998)
D.R. Lock, Z.M. Sthoeger, J. Clin. Gastroenterol. 24, 267–269 (1997)
K.V. Williams, S. Nayak, D. Becker, J. Reyes, L.A. Burmeister, J. Clin. Endocrinol. Metab. 82, 1727–1733 (1997)
L. Bartalena, M.L. Tanda, F. Bogazzi, E. Piantanida, A. Lai, E. Martino, Expert Opin. Pharmacother. 6, 851–861 (2005)
J.L. Sadoul, B. Canivet, P. Freychet, Eur. J. Med. 2, 473–477 (1993)
A. Chan, I. Ng, C.M. Lam, T.W. Shek, C.L. Lai, Hong Kong Med. J. 9, 377–380 (2003)
M.J. Huang, K.L. Li, J.S. Wei, S.S. Wu, K.D. Fan, Y.F. Liaw, Am. J. Gastroenterol. 89, 1071–1076 (1994)
R. Salata, I. Klein, G.S. Levey, Semin. Liver Dis. 5, 29–34 (1985)
N.J. Greenberger, F.D. Milligan, L.J. DeGroot, K.J. Isselbacher, Am. J. Med. 36, 840–846 (1964)
S. Sherlock, Diseases of the liver and biliary system, 7th edn. (Blackwell, Boston, 1985), pp. 399–400
D.C. Beaver, J. Pemberton, Ann. Intern. Med. 7, 687–708 (1993)
H.P. Dooner, J. Parada, C. Aliaga, C. Hoyl, Arch. Intern. Med. 120, 25–32 (1967)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Livadas, S., Xyrafis, X., Economou, F. et al. Liver failure due to antithyroid drugs: report of a case and literature review. Endocr 38, 24–28 (2010). https://doi.org/10.1007/s12020-010-9348-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-010-9348-y